Name | Type | Posted | Actions |
|---|---|---|---|
36C24E26Q0046.docx | DOCX | May 28, 2026 |
V119--Customs Brokerage Services for Import of Pharmaceutical Products
Contact and place of performance
Ann Marie Stewart
Not specified
SUMMARY: This is a Sources Sought notice and not a request for proposals. This request is solely for the purpose of conducting market research to enhance VHA s understanding of the market s offered products, services and capabilities. The Government will not pay any costs for responses submitted in response to this Sources Sought. This Sources Sought notice provides an opportunity for respondents to submit their noti...
View moreThe Department of Veterans Affairs is conducting market research through this Sources Sought notice, identified by solicitation number 36C24E26Q0046, to identify vendors capable of providing customs brokerage and transportation services. The Veterans Health Administration Office of Research & Development requires these services for the import of pharmaceutical products, including drugs, devices, and clinical trial materials, to the VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center in Albuquerque, New Mexico. This requirement is classified under NAICS 488510 for Freight Transportation Arrangement and PSC V119 for TRANSPORTATION/TRAVEL/RELOCATION- TRANSPORTATION: OTHER, and it carries an SBA (SBA) set-aside.
Selected contractors will act as a liaison between the agency, U.S. Customs and Border Protection, and the Food and Drug Administration to facilitate the clearance of shipments primarily originating from Europe. Technical requirements include certification to handle Schedule I-V controlled substances, the maintenance of a continuous bond, and the management of cold chain logistics involving temperature-controlled freight and logging. The vendor will perform clearance and handling services, including duties and taxes, though many research materials may fall under tariff exemptions for experimental use. Responsibilities also include insuring freight during transit and coordinating Power-of-Attorney agreements with VA legal counsel.
The anticipated period of performance consists of a one-year base period followed by four one-year options. Performance will take place at the Clinical Research Pharmacy Coordinating Center in Albuquerque, and the agency requires a centralized point of contact for all shipment details and cost estimates. Capability statements and responses are due by June 4, 2026. This notice was published on May 28, 2026, by point of contact Ann Marie Stewart and includes one attachment titled 36C24E26Q0046.docx.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.